Merck’s Clark: 2009 is a Year of Fundamental Change
Executive Summary
In 2009, Merck is implementing a new business model that fundamentally transforms the company and is crucial to its future, CEO Richard Clark told analysts at a Goldman Sachs health care conference Jan. 7
You may also be interested in...
Merck Continues Looking For The “Right” Biotech Buying Opportunity
Speaking at a Goldman Sachs investor conference, CEO Clark discusses Merck’s plans in biotech.
As Sales Slip, Merck & Co. Plans 7,200 Job Cuts
Facing lower sales of Vytorin, Singulair and Gardasil, on top of recent pipeline disappointments, Merck implements a new restructuring initiative.
Merck Commercial Model: Expand Customer Base, Tighten Marketing Spend
Merck expects to reduce its marketing spend by about 15 to 20 percent per product, Global Pharmaceuticals President Adam Schechter told the Pharmaceutical Strategic Alliances conference in New York on September 25